UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Overall survival analysis of > 65-year-old patients with breast cancer based on their molecular, clinicopathological and laboratory factors

Archives of medical science, 2022, Vol.18 (3), p.800-804

2022

Link zum Volltext

Verfügbarkeit prüfen

Checkpoint Kinase 2 (CHEK2) Mutation in Renal Cell Carcinoma: A Single-Center Experience

Journal of kidney cancer and VHL, 2018-01, Vol.5 (1), p.19-23

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of the neutrophil‑lymphocyte, platelet‑lymphocyte and monocyte‑lymphocyte ratio in breast cancer patients

Oncology letters, 2019-12, Vol.18 (6), p.6275-6283

2019

Link zum Volltext

Verfügbarkeit prüfen

Coexistence of gastrointestinal stromal tumors with other neoplasms

Journal of gastroenterology, 2007-08, Vol.42 (8), p.641-649

2007

Link zum Volltext

Verfügbarkeit prüfen

Outcome of COVID-19 infection in cancer patients during active systemic anticancer treatment. Single-institution experience. A retrospective analysis

Contemporary oncology (Poznań, Poland), 2021-01, Vol.25 (3), p.147-152

2021

Link zum Volltext

Verfügbarkeit prüfen

TP53 mutations and SNPs as prognostic and predictive factors in patients with breast cancer

Oncology letters, 2018-07, Vol.16 (1), p.34-40

2018

Link zum Volltext

Verfügbarkeit prüfen

BRCA2 gene mutation, c.2808_2811delACAA (p.Ala938Profs), in male breast cancer – clinicopathological analysis based on a case report

Przegla̜d menopauzalny, 2019-01, Vol.18 (4), p.227-229

2019

Link zum Volltext

Verfügbarkeit prüfen

The role of the blood platelet-lymphocyte ratio, neutrophil–lymphocyte ratio and platelets in prognosis of metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.670-670

2018

Link zum Volltext

Verfügbarkeit prüfen

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

Contemporary oncology (Poznań, Poland), 2016-01, Vol.20 (1), p.1-7

paper, Review

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological characteristics of breast cancer patients with NOD2 mutation according to age

Contemporary oncology (Poznań, Poland), 2020-01, Vol.24 (2), p.79-86

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for disease progression in HER2-positive breast cancer patients based on the location of metastases

Przegla̜d menopauzalny, 2015-09, Vol.14 (3), p.173-177

2015

Link zum Volltext

Verfügbarkeit prüfen

Answer to the Teresa Pusiol comments to the paper "The association of tumor lymphocyte infiltration with clinico-pathological factor and survival in breast cancer" by Huszno et al

Polish journal of pathology, 2017-01, Vol.68 (3), p.269-269

2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular characteristics of breast cancer according to clinicopathological factors

Molecular and clinical oncology, 2019-08, Vol.11 (2), p.192-200

2019

Link zum Volltext

Verfügbarkeit prüfen

The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma

Oncology, 2019-07, Vol.97 (1), p.7-17

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-08-67: Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio breast cancer patients according to HER2 overexpression

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-08-67

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of the Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios in Male Breast Cancer Patients

Oncology, 2020-07, Vol.98 (7), p.487-492

2020

Link zum Volltext

Verfügbarkeit prüfen

The reproductive cycle in the male gonads of Danio rerio (Teleostei, Cyprinidae). Stereological analysis

Micron (Oxford, England : 1993), 2012-04, Vol.43 (5), p.666-672

2012

Link zum Volltext

Verfügbarkeit prüfen

The use of imatinib in the treatment of inoperable dermatofibrosarcoma protuberans in the area of the shoulder joint

Przegląd dermatologiczny, 2014-01, Vol.3 (3), p.197-200

2014

Link zum Volltext

Verfügbarkeit prüfen

CHEK2 mutation in renal cell carcinoma (RCC): Single center experience

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.480-480

2017

Link zum Volltext

Verfügbarkeit prüfen

BRCA1 mutation in breast cancer patients: Analysis of prognostic factors and survival

Oncology letters, 2019-02, Vol.17 (2), p.1986-1995

2019

Link zum Volltext

Verfügbarkeit prüfen

PR111 TIME FACTOR FOR BREAST CANCER METASTASES DYNAMIC

Breast (Edinburgh), 2013-11, Vol.22, p.S57-S57

2013

Link zum Volltext

Verfügbarkeit prüfen

PO82 CLINICOPATHOLOGICAL ANALYSIS OF THE RISK FACTORS OF DISEASE PROGRESSION IN HER2 POSITIVE BREAST CANCER PATIENTS

Breast (Edinburgh), 2013-11, Vol.22, p.S47-S47

2013

Link zum Volltext

Verfügbarkeit prüfen

Masitinib plus gemcitabine for personalized treatment of PDAC patients with overexpression of ACOX1

Expert review of precision medicine and drug development, 2016-11, Vol.1 (6), p.479-485

2016

Link zum Volltext

Verfügbarkeit prüfen

Role of neutrophil‑lymphocyte ratio, platelet‑lymphocyte ratio, lymphocyte‑monocyte ratio and platelets in prognosis of patients with prostate cancer

Oncology letters, 2022-09, Vol.24 (3), p.1, Article 305

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(46)
Berichte
(2)

Sprache

Englisch
(47)
Polnisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overall survival analysis of > 65-year-old patients with breast cancer based on their molecular, clinicopathological and laboratory factors

Checkpoint Kinase 2 (CHEK2) Mutation in Renal Cell Carcinoma: A Single-Center Experience

Prognostic value of the neutrophil‑lymphocyte, platelet‑lymphocyte and monocyte‑lymphocyte ratio in breast cancer patients

Coexistence of gastrointestinal stromal tumors with other neoplasms

Outcome of COVID-19 infection in cancer patients during active systemic anticancer treatment. Single-institution experience. A retrospective analysis

TP53 mutations and SNPs as prognostic and predictive factors in patients with breast cancer

BRCA2 gene mutation, c.2808_2811delACAA (p.Ala938Profs), in male breast cancer – clinicopathological analysis based on a case report

The role of the blood platelet-lymphocyte ratio, neutrophil–lymphocyte ratio and platelets in prognosis of metastatic renal cell carcinoma (mRCC)

Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients

Clinicopathological characteristics of breast cancer patients with NOD2 mutation according to age

Risk factors for disease progression in HER2-positive breast cancer patients based on the location of metastases

Answer to the Teresa Pusiol comments to the paper "The association of tumor lymphocyte infiltration with clinico-pathological factor and survival in breast cancer" by Huszno et al

Molecular characteristics of breast cancer according to clinicopathological factors

The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma

Abstract P3-08-67: Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio breast cancer patients according to HER2 overexpression

Prognostic Value of the Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios in Male Breast Cancer Patients

The reproductive cycle in the male gonads of Danio rerio (Teleostei, Cyprinidae). Stereological analysis

The use of imatinib in the treatment of inoperable dermatofibrosarcoma protuberans in the area of the shoulder joint

CHEK2 mutation in renal cell carcinoma (RCC): Single center experience

BRCA1 mutation in breast cancer patients: Analysis of prognostic factors and survival

PR111 TIME FACTOR FOR BREAST CANCER METASTASES DYNAMIC

PO82 CLINICOPATHOLOGICAL ANALYSIS OF THE RISK FACTORS OF DISEASE PROGRESSION IN HER2 POSITIVE BREAST CANCER PATIENTS

Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO)

Masitinib plus gemcitabine for personalized treatment of PDAC patients with overexpression of ACOX1

Role of neutrophil‑lymphocyte ratio, platelet‑lymphocyte ratio, lymphocyte‑monocyte ratio and platelets in prognosis of patients with prostate cancer

Suchergebnisse filtern